Prominent Clinical Dimension, Duration of Illness and Treatment Response in Schizophrenia: A Naturalistic Study

被引:22
作者
Buoli, Massimiliano [1 ]
Caldiroli, Alice [1 ]
Panza, Gabriele [1 ]
Altamura, Alfredo Carlo [1 ]
机构
[1] Univ Milan, Dept Psychiat, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, I-20122 Milan, Italy
关键词
Schizophrenia; Clinical dimensions; Antipsychotic response; SCHIZOAFFECTIVE DISORDER; 1ST-EPISODE SCHIZOPHRENIA; NEGATIVE SYMPTOMS; 1ST EPISODE; ARIPIPRAZOLE; DEPRESSION; PSYCHOSIS; ANTIPSYCHOTICS; CLOZAPINE; EFFICACY;
D O I
10.4306/pi.2012.9.4.354
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective Preliminary data indicate that predominant positive symptoms are predictive of subsequent treatment response, while negative and cognitive symptoms are associated with poor outcome. Purpose of the present study was to investigate the relation between the predominant clinical dimension, duration of illness and acute antipsychotic response in a sample of schizophrenic inpatients. Methods Fifty-one schizophrenic inpatients, receiving an antipsychotic mono-therapy, were dimensionally assessed at the admission in the Acute Psychiatric Unit of the University of Milan. Treatment response was selected as parameter of outcome and defined as a reduction >50% of baseline total The Positive and Negative Syndrome Scale (PANSS) score. Demographic and clinical variables between responders and non-responders were compared using one-way analysis of variance for continuous variables and chi(2) test for dichotomous ones. Binary logistic regression was performed to find if dimensional scores and duration of illness were associated with acute antipsychotic response. Results A longer duration of illness was found in non-responders respect to responders (15.61 years vs. 8.28 years)(F=4.98, p=0.03). Higher scores on PANSS positive sub-scale (OR=1.3, p=0.03), lower scores on cognitive PANSS scores (OR=0.75, p=0.05) and shorter duration of illness (OR=0.93, p=0.04) were found to be predictive of acute antipsychotic response. Conclusion These preliminary results show that a long duration of illness as well as a more severe cognitive impairment is predictive of treatment non-response, indicating a worse outcome for chronic patients with predominant cognitive symptoms. Psychiatry investig 2012;9:354-360
引用
收藏
页码:354 / 360
页数:7
相关论文
共 38 条
[1]   A DEPRESSION RATING-SCALE FOR SCHIZOPHRENICS [J].
ADDINGTON, D ;
ADDINGTON, J ;
SCHISSEL, B .
SCHIZOPHRENIA RESEARCH, 1990, 3 (04) :247-251
[2]  
Agid O, 2006, J PSYCHIATR NEUROSCI, V31, P93
[3]  
Altamura AC, 2007, INT CLIN PSYCHOPHARM, V22, P249
[4]   Designing outcome studies to determine efficacy and safety of antipsychotics for 'real world' treatment of schizophrenia [J].
Altamura, A. Carlo ;
Glick, Ira D. .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 (07) :971-973
[5]   Clinical variables related to suicide attempts in schizophrenic patients: a retrospective study [J].
Altamura, AC ;
Bassetti, R ;
Bignotti, S ;
Pioli, R ;
Mundo, E .
SCHIZOPHRENIA RESEARCH, 2003, 60 (01) :47-55
[6]   Duration of illness and duration of untreated illness in relation to drug response in psychiatric disorders [J].
Altamura, Alfredo Carlo ;
Buoli, Massimiliano ;
Serati, Marta .
NEUROPSYCHIATRY, 2011, 1 (01) :81-90
[7]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[8]   CONCURRENT VALIDITY OF THE COGNITIVE COMPONENT OF SCHIZOPHRENIA - RELATIONSHIP OF PANSS SCORES TO NEUROPSYCHOLOGICAL ASSESSMENTS [J].
BELL, MD ;
LYSAKER, PH ;
MILSTEIN, RM ;
BEAMGOULET, JL .
PSYCHIATRY RESEARCH, 1994, 54 (01) :51-58
[9]   Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder [J].
Bilder, RM ;
Goldman, RS ;
Volavka, J ;
Czobor, P ;
Hoptman, M ;
Sheitman, B ;
Lindenmayer, JP ;
Citrome, L ;
McEvoy, J ;
Kunz, M ;
Chakos, M ;
Cooper, TB ;
Horowitz, TL ;
Lieberman, JA .
AMERICAN JOURNAL OF PSYCHIATRY, 2002, 159 (06) :1018-1028
[10]   The psychosis of schizophrenia: Prevalence, response to atypical antipsychotics, and prediction of outcome [J].
Breier, A ;
Berg, PH .
BIOLOGICAL PSYCHIATRY, 1999, 46 (03) :361-364